Uploaded November 2025 | Updated September 2026, 2 weeks ago
Dr. Courtney Lane-Donovan, a physician-scientist at the UCSF Edward and Pearl Fein Memory Aging Center, provided an overview of the current state of Alzheimer's disease treatment and ongoing clinical trials for various neurodegenerative disorders. She discussed the anti-amyloid therapies that have been approved for Alzheimer's disease, the risks and considerations involved in administering these treatments, and the potential future of tau-directed therapeutics. Dr. Lane-Donovan also highlighted clinical trials for frontotemporal dementia, primary progressive aphasia, and progressive supranuclear palsy, encouraging audience members to stay informed and consider participating in these studies to advance the understanding and treatment of these conditions.
Dr. Courtney Lane-Donovan, a physician-scientist at the UCSF Edward and Pearl Fein Memory Aging Center, provided an overview of the current state of Alzheimer's disease treatment and ongoing clinical trials for various neurodegenerative disorders. She discussed the anti-amyloid therapies that have been approved for Alzheimer's disease, the risks and considerations involved in administering these treatments, and the potential future of tau-directed therapeutics. Dr. Lane-Donovan also highlighted clinical trials for frontotemporal dementia, primary progressive aphasia, and progressive supranuclear palsy, encouraging audience members to stay informed and consider participating in these studies to advance the understanding and treatment of these conditions.
